Buy Liberty Caps Mushroom (Psilocybe Semilanceata)
The Liberty caps mushrooms is a hallucinogenic mushroom that grows on grassy meadows and particularly in wet, north-facing fields. The consumption of this mushroom has been outlaw. It is widely distributed through North America but is most common in the Pacific northwest.
some health benefits of liberty caps mushroom
Here are some medical health benefits of Psilocybe semilanceata.
Depression is among the most researched indications for psilocybin therapy. As Healthline previously reported last year, psilocybin therapy given “breakthrough therapy” designation by the FDA for the treatment of depression.
The Usona Institute, a psychedelic research center, is currently in the planning stages of their phase III trial, which will likely begin this year.
smoking cessation and other addictions
In a small pilot study from Johns Hopkins University, researchers found that psilocybin therapy significantly improve abstaining from smoking over a 12-month follow-up period.
Matthew Johnson, PhD, associate professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine, led that study.
According to him, psilocybin also has potential to treat other substance use disorders, including alcohol and cocaine addiction.
“The general idea is that the nature of these disorders is a narrowed mental and behavioral repertoire,”. “So, [psilocybin] in well-orchestrated sessions [has] the ability to essentially shake someone out of their routine to give a glimpse of a larger picture and create a mental plasticity with which people can step outside of those problems.”
Researchers in Alabama are also currently conducting trials for psilocybin therapy on cocaine addiction.
cancer-related psychological distress
“There’ve been some promising preliminary results in such areas such as the treatment of overwhelming existential anxiety in people who are facing the end of life, who have diagnoses of advanced-stage cancer,” Dr. Charles Grob, professor of psychiatry at the UCLA David Geffen School of Medicine, told Healthline.
Grob, who’s also affiliated with the Heffter Research Institute, has studied psilocybin extensively and authored research on the subject, including, among other things, a pilot study in 2011 on psilocybin treatment for anxiety in people with cancer.
A randomize, double-blind trial from Johns Hopkins in 2016 found that a single dose of psilocybin substantially improved quality of life and decreased depression and anxiety in people with life-threatening cancer diagnoses.
“The thing that we have the most evidence for is cancer-relate depression and anxiety. That seems really strong, and I’d be surprised if those results didn’t hold up,” Johnson said, who was part of that research.